SCHEMBL7124462

SCHEMBL7124462

CC(C)(C)C(CCc1ccccc1)(NS(=O)(=O)c1ccccc1)C(N)=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.45
GHSR Q92847 1/20 0.43
PRMT1 Q99873 1/20 0.43
ALDH1A1 P00352 6/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
MAPT P10636 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
TSHR P16473 1/20 0.39
LARS1 Q9P2J5 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7127820 0.93 GHSR (0.43) GAAGHSRPRMT1ALDH1A1CA12
SCHEMBL7127023 0.92 GHSR (0.42) GAAGHSRPRMT1ALDH1A1CA12
SCHEMBL7121674 0.90 ALDH1A1 (0.54) ALDH1A1MAPTMMP13SMN1; SMN2MMP2
SCHEMBL7118409 0.89 ALDH1A1 (0.48) GAAALDH1A1CA12CA1CA2
SCHEMBL7125294 0.89 KMT2A (0.58) GAAGHSRALDH1A1CYP1A2CYP2C19
SCHEMBL7116832 0.82 CA9 (0.39) GHSRCYP1A2CA12CA1CA2
SCHEMBL7126170 0.81 F2 (0.46) ALDH1A1CA1CA2MEN1KMT2A
SCHEMBL6497984 0.76 CYP2C19 (0.43) GAAALDH1A1CYP2C19CA1CA2
SCHEMBL6803588 0.71 HDAC3 (0.50) ALDH1A1MEN1KMT2AMAPTNPC1
SCHEMBL8742349 0.71 ATM (0.43) GAAALDH1A1CYP2C19CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6583318-B2 Carrying out a four component condensation reaction between components consisting of a sulfonamide, an aldehyde or ketone, an isocyanide and a carboxylic acid, and one of such components being attached to a solid support ADVANCED SYNTECH, LLC 2003-06-24 US disclosed
US-20030013910-A1 Method for synthesis of alpha-sulfonamido amide, carboxylic acid and hydroxamic acid derivatives ADVANCED SYNTECH LLC 2003-01-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030013910-A1 Method for synthesis of alpha-sulfonamido amide, carboxylic acid and hydroxamic acid derivatives ASPH, COASY, HAAO GAA 365/4885GHSR 2089/4885PRMT1 2833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.